NervGen Pharma Corp. (NGEN)
3.75
-0.10
(-2.60%)
USD |
NASDAQ |
May 08, 16:00
3.745
0.00 (0.00%)
After-Hours: 20:00
NervGen Pharma Total Liabilities (Quarterly) : 14.40M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | 37.17M |
| Lexaria Bioscience Corp. | 0.277M |
| InMed Pharmaceuticals, Inc. | 2.242M |
| Target Group, Inc. (Canada) | 14.24M |
| Tilray Brands, Inc. | 549.12M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.93M |
| Shareholders Equity (Quarterly) | 2.536M |
| Debt to Equity Ratio | 0.0024 |
| Current Ratio | 1.156 |
| Net Debt Paydown Yield | 0.00% |